IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bellicum Pharmaceuticals Inc

CUSIP: 079481107 | 273 institutional holders

Quarters

Q2 2020Q1 2020Q4 2019Q3 2019Q2 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2020

X-Square Capital, LLC22,374
0.0% of portfolio›$166
StyleTurnoverLocationFiled
X-Square Capital, LLC
22,374$1660.0%GARPMediumGuaynabo, PR2020-08-13